Q News and Research

RSS

Bentracimab reverses ticagrelor's antiplatelet effects during surgery and bleeding events

A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor's antiplatelet effects in patients undergoing urgent surgery or experiencing major bleeding, according to a study presented at the American College of Cardiology's Annual Scientific Session (ACC.25).

29 Mar 2025

Semaglutide improves maximal walking distance in people with symptomatic PAD and Type 2 diabetes

Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with symptomatic peripheral artery disease (PAD) and Type 2 diabetes in the first-of-its kind trial to evaluate the use of a GLP-1 agonist to manage PAD.

29 Mar 2025

Study finds 4F-PCC superior to frozen plasma in reducing bleeding after cardiac surgery

In patients experiencing excessive bleeding during cardiac surgery, a concentrated blood product containing proteins that help the blood clot was significantly more effective and caused fewer adverse effects than frozen plasma, the standard therapy, according to a study presented at the American College of Cardiology's Annual Scientific Session (ACC.25).

29 Mar 2025

Research reveals optimal duration of dual antiplatelet therapy after stent implantation

Patients who have a stent implanted to open a blocked coronary artery face dual risks of developing blood clots and of having excessive bleeding in the months following the procedure.

29 Mar 2025

Reduced-dose apixaban proves effective in preventing blood clot recurrence in cancer patients

Patients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning medication for at least six months, followed by an additional 12 months of low-dose apixaban, experienced similar VTE recurrences and less bleeding as similar patients who received a full dose of the oral blood-thinning medication over the same extended period.

29 Mar 2025

Rivaroxaban shown to be a viable alternative to warfarin for left ventricular thrombus

At three months of follow-up, patients hospitalized for a serious heart attack who were treated with the oral blood thinner rivaroxaban for a blood clot in the left ventricle did as well as similar patients who received standard treatment with warfarin, an older blood-thinning drug.

29 Mar 2025

The impact of ending U.S.-funded global vaccine programs

Abram Wagner, assistant professor of epidemiology and global public health at the University of Michigan School of Public Health, discusses implications of the U.S. potentially ending global vaccine programs.

27 Mar 2025

Microplastics exposure linked to increased risk of chronic diseases

Tiny fragments of plastic have become ubiquitous in our environment and our bodies. Higher exposure to these microplastics, which can be inadvertently consumed or inhaled, is associated with a heightened prevalence of chronic noncommunicable diseases, according to new research being presented at the American College of Cardiology's Annual Scientific Session (ACC.25).

25 Mar 2025

Increased mobility linked to lower risk of hospitalization in heart failure patients

Compared with those who spent most of their time in a single room, people with heart failure with preserved ejection fraction (HFpEF) who were able to travel outside of their home without assistance were significantly less likely to be hospitalized or die within a year, according to a study being presented at the American College of Cardiology's Annual Scientific Session (ACC.25).

25 Mar 2025

Cardiovascular-related maternal mortality has more than doubled since 1999

The rate of maternal mortality related to cardiovascular causes more than doubled between 1999 and 2022 in the United States, according to a study being presented at the American College of Cardiology's Annual Scientific Session (ACC.25).

25 Mar 2025

New evidence suggests HPV could increase risk of coronary artery disease

In addition to causing several types of cancer, human papillomavirus (HPV) appears to bring a significantly increased risk of heart disease and coronary artery disease, according to a study being presented at the American College of Cardiology's Annual Scientific Session (ACC.25).

25 Mar 2025

Smartwatch data could offer new way to assess cardiovascular health

The answer to your heart health may be on your wrist, a new study suggests. Researchers have developed a new way to assess cardiovascular health based on information routinely collected by smartwatches, according to a study being presented at the American College of Cardiology's Annual Scientific Session (ACC.25).

20 Mar 2025

Colorectal cancer patients face increased risk of cardiovascular death

People diagnosed with colorectal cancer are significantly more likely to die of cardiovascular causes than the general population, especially in the first two years after their cancer diagnosis and in people younger than 50, according to a study being presented at the American College of Cardiology's Annual Scientific Session (ACC.25).

20 Mar 2025

AI technology in mammograms could predict heart disease in women

Mammograms, with the help of artificial intelligence (AI) models, may reveal much more than cancer, according to a study being presented at the American College of Cardiology's Annual Scientific Session (ACC.25).

20 Mar 2025

Oophorectomy linked to higher risk of heart failure in women

Women of childbearing age who had both ovaries removed, in a procedure called bilateral oophorectomy, were more likely to develop heart failure later in life, according to a study being presented at the American College of Cardiology's Annual Scientific Session (ACC.25).

20 Mar 2025

New cannabis formula will help epilepsy, multiple sclerosis sufferers

Scientists at the University of South Australia have come up with an innovative solution to improve the effectiveness of cannabidiol to treat epilepsy, multiple sclerosis and other neurodegenerative diseases.

20 Mar 2025

Cambridge and London hospitals to pioneer brain implants to combat alcohol and opioid addiction

People suffering from severe alcohol and opioid addiction are to be offered a revolutionary new technique involving planting electrodes in the brain to modulate brain activity and cravings and improve self-control.

19 Mar 2025

Lifestyle and health factors have greater impact on cardiovascular risk in women than men

Lifestyle and health factors that are linked with heart disease appear to have a greater impact on cardiovascular risk in women than men, according to a study being presented at the American College of Cardiology's Annual Scientific Session (ACC.25).

18 Mar 2025

Healthy plant-based diets linked to longer life for people with cardiometabolic disorders

People with cardiometabolic disorders—such as obesity, diabetes and heart disease—could increase their chances of living longer by adopting a healthy plant-based diet, according to a study being presented at the American College of Cardiology's Annual Scientific Session (ACC.25).

18 Mar 2025

Cyanotic congenital heart disease incidence increases in states with restrictive abortion laws

The incidence of babies born with serious heart defects, known as cyanotic congenital heart disease (CCHD), rose in states that enacted restrictive abortion laws following the U.S. Supreme Court's 2022 ruling that put abortion laws in the hands of the states, according to a study being presented at the American College of Cardiology's Annual Scientific Session.

18 Mar 2025

Q News and Research

Bentracimab reverses ticagrelor's antiplatelet effects during surgery and bleeding events

Semaglutide improves maximal walking distance in people with symptomatic PAD and Type 2 diabetes

Study finds 4F-PCC superior to frozen plasma in reducing bleeding after cardiac surgery

Research reveals optimal duration of dual antiplatelet therapy after stent implantation

Reduced-dose apixaban proves effective in preventing blood clot recurrence in cancer patients

Rivaroxaban shown to be a viable alternative to warfarin for left ventricular thrombus

The impact of ending U.S.-funded global vaccine programs

Microplastics exposure linked to increased risk of chronic diseases

Increased mobility linked to lower risk of hospitalization in heart failure patients

Cardiovascular-related maternal mortality has more than doubled since 1999

New evidence suggests HPV could increase risk of coronary artery disease

Smartwatch data could offer new way to assess cardiovascular health

Colorectal cancer patients face increased risk of cardiovascular death

AI technology in mammograms could predict heart disease in women

Oophorectomy linked to higher risk of heart failure in women

New cannabis formula will help epilepsy, multiple sclerosis sufferers

Cambridge and London hospitals to pioneer brain implants to combat alcohol and opioid addiction

Lifestyle and health factors have greater impact on cardiovascular risk in women than men

Healthy plant-based diets linked to longer life for people with cardiometabolic disorders

Cyanotic congenital heart disease incidence increases in states with restrictive abortion laws

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News